1.Preliminary study on lacquer figure with meridian-points marked of the western Han dynasty unearthed in Laoguanshan, Chengdu.
Fanrong LIANG ; Zeng FANG ; Xinglan ZHOU ; Tao XIE ; Yinke LU ; Yi WANG ; Zhang-hua JIANG
Chinese Acupuncture & Moxibustion 2015;35(1):91-93
The lacquer figure with meridian-points marked of the western Han dynasty, unearthed in Tianhui town, Jinniu district, Chengdu in 2012, has been the earliest and the most complete human figure of meridian-acupoints in China so far. There were over ten courses of meridians, and over 100 visible acupoints as well as multiple intaglio inscriptions. All of them are valuable in academic study. The writers introduced the lacquer figure un- earthed in Laoguanshan in terms of the briefs and characteristics of meridian and acupoint distributions, which give the references to the future studies.
Acupuncture
;
history
;
instrumentation
;
Acupuncture Points
;
China
;
History, Ancient
;
Human Body
;
Humans
;
Meridians
2.Efficacy comparison of 3 rivaroxaban regimen in patients with venous thromboembolism.
Qin ZHOU ; Yan WU ; Xin JIANG ; Xinglan LIU ; Han LEI ; Zhicheng JING ; Wei HUANG
Chinese Journal of Cardiology 2015;43(9):782-784
OBJECTIVETo compare the efficacy and safety of 3 rivaroxaban regimen in patients with venous thromboembolism (VTE).
METHODSThis is a retrospective study. Thirty three inpatients with VTE received rivaroxaban were divided into 3 groups, in which 16 patients were treated with 15 mg rivaroxaban twice daily for 21 days then followed by 20 mg once per day till 3 months (group 1), 9 patients were treated with 20 mg rivaroxaban once daily for 3 months (group 2), 8 patients were treated with 10 mg rivaroxaban once daily for 3 months. The reduction rate of D-Dimer on the third therapy day, the duration of D-Dimer normalization and hospital stay as well as symptom remission, the imaging assessment results after three months treatment, rate of recurrent VTE, bleeding, liver and kidney function were compared among the 3 groups.
RESULTSThe reduction rates of D-Dimer on the third therapy day were significantly higher ((46.12 ± 15.42) % vs. (26.59 ± 8.11) % and (25.55 ± 14.00) %, P = 0.02, P = 0.01), and the duration of D-Dimer normalization was significantly shorter ((17.9 ± 7.7) days vs. (24.1 ± 5.1) days and (26.3 ± 6.2) d, P = 0.03, P < 0.01) in group 1 than in group 2 and 3. There was one recurrent deep-vein thrombosis in group 3, one non-major bleeding in group 1 and group 3. Major bleeding or liver and kidney dysfunction were not observed in these patients.
CONCLUSIONSVenous thromboembolism can be safely and effectively treated by rivaroxaban, and does of 15 mg twice daily for 21 days followed by 20 mg once daily for 3 months are superior to the other 2 tested therapy regimen in this patient cohort.
Fibrin Fibrinogen Degradation Products ; Hemorrhage ; Humans ; Length of Stay ; Retrospective Studies ; Rivaroxaban ; Venous Thromboembolism ; Venous Thrombosis
3.Analysis on the Causes of Clinical Return of PIVAS Finished Infusions in Our Hospital and Discussion on Intervention Strategies
Yang YANG ; Jie WANG ; Hongzi DING ; Qiuyun ZHOU ; Feng ZHAO ; Xinglan LU
China Pharmacy 2017;28(34):4894-4896
OBJECTIVE:To provide reference for reducing the clinical return of finished infusions. METHODS:Interventions for clinical return of PIVAS finished infusions in our hospital were introduced,the return situation of finished infusions before(dur-ing 2013-2014)and after(during 2015-2016)intervention was compared,and intervention effects were evaluated. RESULTS:Our hospital intervened it by rationally selecting and using syringes,strengthening visible particle check of finished infusion before dis-tribution;optimizing the order of drug configuration,reasonably arranging the drug infusion sequence;strengthening the clean-up in work area before drug infusion,correctly using disinfectant;strictly implementing intravenous infusion associative operation, playing the role of pharmacists;cultivating good work habits,and strengthening teamwork,etc. Compared with before interven-tion,the return numbers of finished infusion were decreased by 41.2%,and reported loss amount reduced by 45.7%. The return caused by visibility particles,finished infusion oxidation discoloration after too long storage time,finished infusion leakage,contin-uous infusion of drugs compatibility,heterodyne error,improper drug configuration method in packaging to the ward,improper use of disinfectant before infusion decreased by 25.3%,46.9%,39.4%,77.8%,73.9%,75.0%,100%,respectively. CONCLU-SIONS:Intervening the return of finished infusion can reduce the return numbers and drug waste.